Triton to invest in Bergman Clinics in partnership with existing shareholders

09.03.2021

Frankfurt (Germany), Naarden (Netherlands), 9 March 2021 - Triton Fund V advised by Triton (“Triton”) has signed an agreement to invest in Bergman Clinics (“Bergman Clinics”), one of the leading chains of independent clinics in the Netherlands, Germany and Scandinavia. This investment will be in partnership with the current shareholders consisting of the Malenstein family and NPM Capital. The agreement is subject to the completion of the consultation process with Bergman Clinics’ works council and customary regulatory approvals. Terms and conditions of the transaction are not disclosed.

“We are excited to support the management and employees of Bergman Clinics by investing in and supporting the growth and European expansion of the clinics network,” said Peder Prahl, Director of the General Partner for the Triton funds.

Bergman Clinics is a leading specialist for treatments in the field of orthopedics, ophthalmology, gynecology, aesthetic medicine, cardiology, gastroenterology, dermatology, and vascular medicine. Bergman Clinics grew its network of clinics through an active acquisition strategy, first in the Dutch home market, later on in Scandinavia and Germany. Bergman Clinics currently owns 140 focus clinics throughout the Netherlands, Sweden, Denmark, Norway, and Germany which offer high quality, plannable medical care, with clients and their conditions at the heart of their activities.

The investment by Triton will help Bergman Clinics to further expand its geographical footprint, and creates room to invest in technological innovation, digitization and training. Both clients and employees can benefit directly from this.

“Bergman Clinics is strongly positioned in the field of outpatient care which is an increasingly important part of the healthcare services sector. The company has a strong medical platform and digital backbone to further expand as a focused specialty care player in Europe,” emphasized Anja Bickelmaier, Co-Head of Healthcare at Triton.

“The clinic has a strong brand in the Netherlands and we are looking forward to support its development in core markets where Triton has been investing for more than two decades,” added Koos van de Linde, Investment Advisory Professional at Triton.

“We are pleased to welcome Triton as a new investor and strong partner who will support Bergman Clinics’ ongoing journey towards high-quality client-oriented treatment at affordable prices. We will not only benefit from Triton’s expertise in the healthcare sector and in particular in healthcare services, but also from its international network,” said Hans van der Heijden, CEO of Bergman Clinics.

Bart Malenstein, Owner and Member of the Supervisory Board of Bergman Clinics added: “Triton is the ideal partner to shape the future of Bergman Clinics. Triton has extensive experience in the healthcare sector and a broad network within its portfolio that can help us by exchanging knowledge and best practices across several areas and regions, benefiting clients who are at the heart of what we do.”

 

About Bergman Clinics

For nearly 30 years, Bergman Clinics has been one of the leading chains of independent clinics with 140 focus clinics throughout the Netherlands, Sweden, Denmark, Norway, and Germany. The focus clinics offer high quality, plannable medical care, with patients and the condition at the core. Bergman Clinics is a leading specialist for treatments in the field of orthopedics, ophthalmology, gynecology, aesthetic medicine, cardiology, gastroenterology, dermatology, and vascular medicine. Bergman Clinics treats more than 300,000 patients every year in the Netherlands, Germany, and Scandinavia. More than 3,000 employees and more than 250 specialists work at Bergman Clinics.

For more information:  https://www.bergmanclinics.nl/

About Triton

Since its establishment in 1997, Triton has sponsored nine funds, focusing on businesses in the industrial, business services, consumer and health sectors. The Triton funds invest in and support the positive development of medium-sized businesses headquartered in Europe.

Triton seeks to contribute to the building of better businesses for the longer term. Triton and its executives wish to be agents of positive change towards sustainable operational improvements and growth.

The 46 companies currently in Triton's portfolio have combined sales of around €18.2 billion and around 100,800 employees.

For further information: www.triton-partners.com

Press Contacts

Triton
Anja Schlenstedt
Bergman Clinics
Christiaan Boer